| Cancer stemness, intratumoral heterogeneity, and immune response across cancers A Miranda, PT Hamilton, AW Zhang, S Pattnaik, E Becht, A Mezheyeuski, ... Proceedings of the National Academy of Sciences 116 (18), 9020-9029, 2019 | 398 | 2019 |
| STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer C Pena, MV Céspedes, MB Lindh, S Kiflemariam, A Mezheyeuski, ... Cancer research 73 (4), 1287-1297, 2013 | 203 | 2013 |
| Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity N Tanaka, S Kanatani, R Tomer, C Sahlgren, P Kronqvist, D Kaczynska, ... Nature Biomedical Engineering 1 (10), 796-806, 2017 | 164 | 2017 |
| Multispectral imaging for quantitative and compartment‐specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients A Mezheyeuski, CH Bergsland, M Backman, D Djureinovic, T Sjöblom, ... The Journal of pathology 244 (4), 421-431, 2018 | 163 | 2018 |
| Targeting MARCO and IL37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function L La Fleur, J Botling, F He, C Pelicano, C Zhou, C He, G Palano, ... Cancer Research 81 (4), 956-967, 2021 | 117 | 2021 |
| Impact of epithelial–stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ C Strell, J Paulsson, SB Jin, NP Tobin, A Mezheyeuski, P Roswall, ... JNCI: Journal of the National Cancer Institute 111 (9), 983-995, 2019 | 116 | 2019 |
| Guidance molecule SEMA3A restricts tumor growth by differentially regulating the proliferation of tumor-associated macrophages M Wallerius, T Wallmann, M Bartish, J Östling, A Mezheyeuski, NP Tobin, ... Cancer research 76 (11), 3166-3178, 2016 | 60 | 2016 |
| Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome A Mezheyeuski, U Segersten, LW Leiss, PU Malmström, J Hatina, ... Scientific reports 10 (1), 281, 2020 | 52 | 2020 |
| A minority-group of renal cell cancer patients with high infiltration of CD20+ B-cells is associated with poor prognosis E Sjöberg, M Frödin, J Lövrot, A Mezheyeuski, M Johansson, ... British journal of cancer 119 (7), 840-846, 2018 | 50 | 2018 |
| Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter-and intra-patient heterogeneity and impact on survival S Corvigno, GBA Wisman, A Mezheyeuski, AGJ van der Zee, HW Nijman, ... Oncotarget 7 (14), 18573, 2016 | 50 | 2016 |
| Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients KØ Aasebø, A Dragomir, M Sundström, A Mezheyeuski, PH Edqvist, ... Cancer Medicine 8 (7), 3623-3635, 2019 | 48 | 2019 |
| CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup K Aasebø, A Dragomir, M Sundström, A Mezheyeuski, PH Edqvist, ... Frontiers in oncology 10, 8, 2020 | 42 | 2020 |
| Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma M Frödin, A Mezheyeuski, S Corvigno, U Harmenberg, P Sandström, ... British journal of cancer 116 (2), 195-201, 2017 | 42 | 2017 |
| Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC C Strell, KJ Norberg, A Mezheyeuski, J Schnittert, PR Kuninty, CF Moro, ... British journal of cancer 117 (1), 65-77, 2017 | 41 | 2017 |
| Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer A Mezheyeuski, MB Lindh, TK Guren, A Dragomir, P Pfeiffer, EH Kure, ... Oncotarget 7 (27), 41948, 2016 | 36 | 2016 |
| The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types P Micke, C Strell, J Mattsson, A Martín-Bernabé, H Brunnström, J Huvila, ... EBioMedicine 65, 2021 | 34 | 2021 |
| Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma S Lundgren, J Elebro, M Heby, B Nodin, K Leandersson, P Micke, ... International Journal of Cancer 146 (12), 3461-3473, 2020 | 33 | 2020 |
| Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis L Nunes, K Aasebø, L Mathot, V Ljungström, PH Edqvist, M Sundström, ... Acta Oncologica 59 (4), 417-426, 2020 | 32 | 2020 |
| Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation P Moreno-Ruiz, S Corvigno, NC Te Grootenhuis, L La Fleur, M Backman, ... Lung Cancer 155, 10-19, 2021 | 29 | 2021 |
| A comprehensive evaluation of associations between routinely collected staging information and the response to (chemo) radiotherapy in rectal cancer K Hammarström, I Imam, A Mezheyeuski, J Ekström, T Sjöblom, ... Cancers 13 (1), 16, 2020 | 29 | 2020 |
